scispace - formally typeset
N

Nicolas Joudiou

Researcher at Université catholique de Louvain

Publications -  36
Citations -  639

Nicolas Joudiou is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: In vivo & Melanoma. The author has an hindex of 10, co-authored 30 publications receiving 394 citations. Previous affiliations of Nicolas Joudiou include French Institute of Health and Medical Research & Joseph Fourier University.

Papers
More filters
Journal ArticleDOI

Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.

TL;DR: It is demonstrated that GemC12‐LNC hydrogel could be considered as a promising tool for the post‐resection management of GBM, prior to the standard of care chemo‐radiation.
Journal ArticleDOI

Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.

TL;DR: The PTX and TMZ codelivery hydrogel showed superior antitumor effects and can be considered a promising approach for the postsurgical treatment of GBM.
Journal ArticleDOI

Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.

TL;DR: It is hypothesized that the intra‐operative injection of a photopolymerizable hydrogel into the tumor resection cavity could sustain the release of the anti‐cancer drug paclitaxel (PTX) encapsulated in poly (lactic‐co‐glycolic acid) (PLGA) nanoparticles and prevent GBM recurrence.
Journal ArticleDOI

Quantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions.

TL;DR: A numerical approach was used to examine the influence on T2*, blood volume fraction, and StO2 estimates of possible confounding factors such as water diffusion, intravascular signal, and presence of arterial blood in the voxel to indicate that the models are sufficiently realistic.